# Clinical Trail to Evaluate the Effect of Long-term Treatment With Gecacitinib on Myelofibrosis and Gene Mutation Levels

> **NCT07342712** · — · ACTIVE_NOT_RECRUITING · sponsor: **First Affiliated Hospital of Zhejiang University** · enrollment: 40 (estimated)

## Conditions studied

- Myelofibrosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07342712
- **Lead sponsor:** First Affiliated Hospital of Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2026-04-01
- **Final completion:** 2027-12-07
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07342712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07342712, "Clinical Trail to Evaluate the Effect of Long-term Treatment With Gecacitinib on Myelofibrosis and Gene Mutation Levels". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT07342712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*